in this issue
Chemical Week Magazine :: Business & Finance :: United States/Americas
Chr. Hansen Buys Biotech Firm
February 9, 2009
Chr. Hansen has acquired privately owned biotech firm Urex Biotech (Toronto), which focuses on human health and nutrition concerns. Terms were not disclosed. The deal expands Chr. Hansen’s portfolio of probiotics for dietary supplements, Chr. Hansen says. The companies partnered in 2004 to develop therapeutic products based on probiotic strains, targeting women’s health...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee